Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …

JHN Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - Am Heart Assoc
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …

[HTML][HTML] Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content

H Abdul-Hussien, R Hanemaaijer, JH Verheijen… - Journal of vascular …, 2009 - Elsevier
BACKGROUND: Matrix metalloproteinase-9 (MMP-9) is thought to play a central role in
abdominal aortic aneurysm (AAA) initiation. Doxycycline, a tetracycline analogue, has direct …

[HTML][HTML] Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic …

JA Curci, D Mao, DG Bohner, BT Allen, BG Rubin… - Journal of vascular …, 2000 - Elsevier
Purpose: Matrix metalloproteinases (MMPs) are considered to play a central role in the
pathogenesis of abdominal aortic aneurysms (AAAs). Doxycycline (Dox) has direct MMP …

[HTML][HTML] Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease

JR Boyle, E McDermott, M Crowther, AD Wills… - Journal of vascular …, 1998 - Elsevier
Purpose: Abdominal aortic aneurysms are characterized by degradation of the extracellular
matrix, with a reduction in the elastin concentration of the arterial media. These changes are …

[HTML][HTML] Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines

JA Curci, D Petrinec, S Liao, LM Golub… - Journal of vascular …, 1998 - Elsevier
Background: Matrix metalloproteinases (MMPs) likely contribute to the degradation of medial
elastin in abdominal aortic aneurysms (AAAs), and tetracycline antibiotics exhibit MMP …

Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study

BT Baxter, WH Pearce, EA Waltke, FN Littooy… - Journal of vascular …, 2002 - Elsevier
Background: The primary purpose of this study was to evaluate compliance, side effects, and
safety associated with prolonged administration of doxycycline in patients with small …

Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis

IJ Franklin, SL Harley, RM Greenhalgh… - Journal of British …, 1999 - academic.oup.com
Background Proteolytic degradation of the aortic wall by matrix metalloproteinases (MMPs)
is considered important in the pathogenesis of abdominal aortic aneurysms (AAAs). Many of …

[HTML][HTML] A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair

AE Hackmann, BG Rubin, LA Sanchez… - Journal of vascular …, 2008 - Elsevier
BACKGROUND: The late durability of endovascular aneurysm repair (EVAR) has been
limited by progressive aortic degeneration believed to be mediated by matrix …

[HTML][HTML] Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells

J Liu, W Xiong, L Baca-Regen, H Nagase… - Journal of vascular …, 2003 - Elsevier
Degradation of the extracellular matrix components elastin and collagen has been
implicated in vascular diseases, including abdominal aortic aneurysm (AAA) and …

Doxycycline inhibition of abdominal aortic aneurysm growth-a systematic review of the literature

BR Dodd, RA Spence - Current vascular pharmacology, 2011 - ingentaconnect.com
Abdominal aortic aneurysm (AAA) is a common disease and a major cause of death through
rupture, the risk of which increases with aneurysm size. There is approximately a 5 year …